BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
-2.92%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$2.45B
AUM Growth
+$2.45B
(-8.1%)
Cap. Flow
+$13.9M
Cap. Flow
% of AUM
0.57%
Top 10 Holdings %
Top 10 Hldgs %
48.53%
Holding
78
New
8
Increased
20
Reduced
11
Closed
4
Top Buys
| 1 |
Galapagos
GLPG
|
$58.9M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$49.4M |
| 3 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$33.7M |
| 4 |
Kymera Therapeutics
KYMR
|
$32.3M |
| 5 |
Tyra Biosciences
TYRA
|
$29.8M |
Top Sells
| 1 |
Merus
MRUS
|
$153M |
| 2 |
argenx
ARGX
|
$86.1M |
| 3 |
Relay Therapeutics
RLAY
|
$28M |
| 4 |
Forte Biosciences
FBRX
|
$19.9M |
| 5 |
Immunovant
IMVT
|
$13.5M |
Sector Composition
| 1 | Healthcare | 98.3% |
| 2 | Financials | 0.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Immunovant
IMVT
$2.91B
| – | – |
-1,273,516
| Closed | -$13.5M |
|
|
77
Forte Biosciences
FBRX
$138M
| – | – |
-591,811
| Closed | -$19.9M |
|
|
CNTA
78
Centessa Pharmaceuticals
CNTA
$2.13B
| – | – |
-58,900
| Closed | -$1.31M |
|